Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Alzheimers Dement. 2018 Oct 12;15(1):55–64. doi: 10.1016/j.jalz.2018.08.006

Figure 4, GAP-43 concentration increased with the number of APOE ε4 alleles.

Figure 4,

A, GAP-43 concentration increased with the number of APOE ε4 alleles across all diagnostic groups. B, GAP-43 concentration decreased with the number of APOE ε3 alleles across all diagnostic groups. C, GAP-43 concentration increased with the number of APOE ε4 alleles in AD and D, MCI. *; p < 0.05, ****; p < 0.0001. AD: Alzheimer’s disease, MCI: mild cognitive impairment patients.